BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 2136707)

  • 1. Identification of HIV-1 vpr product and function.
    Cohen EA; Terwilliger EF; Jalinoos Y; Proulx J; Sodroski JG; Haseltine WA
    J Acquir Immune Defic Syndr (1988); 1990; 3(1):11-8. PubMed ID: 2136707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus vpr product is a virion-associated regulatory protein.
    Cohen EA; Dehni G; Sodroski JG; Haseltine WA
    J Virol; 1990 Jun; 64(6):3097-9. PubMed ID: 2139896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 Vpr transactivates LTR-directed expression through sequences present within -278 to -176 and increases virus replication in vitro.
    Vanitharani R; Mahalingam S; Rafaeli Y; Singh SP; Srinivasan A; Weiner DB; Ayyavoo V
    Virology; 2001 Oct; 289(2):334-42. PubMed ID: 11689055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 viral protein R (Vpr) regulates viral replication and cellular proliferation in T cells and monocytoid cells in vitro.
    Ayyavoo V; Mahalingam S; Rafaeli Y; Kudchodkar S; Chang D; Nagashunmugam T; Williams WV; Weiner DB
    J Leukoc Biol; 1997 Jul; 62(1):93-9. PubMed ID: 9225999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral protein R of human immunodeficiency virus types 1 and 2 is dispensable for replication and cytopathogenicity in lymphoid cells.
    Dedera D; Hu W; Vander Heyden N; Ratner L
    J Virol; 1989 Jul; 63(7):3205-8. PubMed ID: 2524599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a cytopathogenicity determinant in HIV-1 Vpr.
    Somasundaran M; Sharkey M; Brichacek B; Luzuriaga K; Emerman M; Sullivan JL; Stevenson M
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9503-8. PubMed ID: 12093916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The putative alpha helix 2 of human immunodeficiency virus type 1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth-arrested cells.
    Nie Z; Bergeron D; Subbramanian RA; Yao XJ; Checroune F; Rougeau N; Cohen EA
    J Virol; 1998 May; 72(5):4104-15. PubMed ID: 9557700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein.
    Wu X; Liu H; Xiao H; Conway JA; Hunter E; Kappes JC
    EMBO J; 1997 Aug; 16(16):5113-22. PubMed ID: 9305652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Functional roles of HIV-1 accessory genes for its pathogenicity].
    Adachi A; Kamada K; Hatcho K; Yamashita T; Uchiyama T; Nomaguchi M
    Tanpakushitsu Kakusan Koso; 2007 Aug; 52(10 Suppl):1261-7. PubMed ID: 17824250
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell cycle- and Vpr-mediated regulation of human immunodeficiency virus type 1 expression in primary and transformed T-cell lines.
    Gummuluru S; Emerman M
    J Virol; 1999 Jul; 73(7):5422-30. PubMed ID: 10364289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo.
    Zimmerman ES; Sherman MP; Blackett JL; Neidleman JA; Kreis C; Mundt P; Williams SA; Warmerdam M; Kahn J; Hecht FM; Grant RM; de Noronha CM; Weyrich AS; Greene WC; Planelles V
    J Virol; 2006 Nov; 80(21):10407-18. PubMed ID: 16956949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of HIV-1 transcription and replication by a Vpr mutant.
    Sawaya BE; Khalili K; Rappaport J; Serio D; Chen W; Srinivasan A; Amini S
    Gene Ther; 1999 May; 6(5):947-50. PubMed ID: 10505122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses.
    Kishi M; Nishino Y; Sumiya M; Ohki K; Kimura T; Goto T; Nakai M; Kakinuma M; Ikuta K
    J Gen Virol; 1992 Jan; 73 ( Pt 1)():77-87. PubMed ID: 1730943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional role of human immunodeficiency virus type 1 vpu.
    Terwilliger EF; Cohen EA; Lu YC; Sodroski JG; Haseltine WA
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5163-7. PubMed ID: 2472639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vpr cytopathicity independent of G2/M cell cycle arrest in human immunodeficiency virus type 1-infected CD4+ T cells.
    Bolton DL; Lenardo MJ
    J Virol; 2007 Sep; 81(17):8878-90. PubMed ID: 17553871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virion-Associated Vpr Alleviates a Postintegration Block to HIV-1 Infection of Dendritic Cells.
    Miller CM; Akiyama H; Agosto LM; Emery A; Ettinger CR; Swanstrom RI; Henderson AJ; Gummuluru S
    J Virol; 2017 Jul; 91(13):. PubMed ID: 28424288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vpr and Vpu are important for efficient human immunodeficiency virus type 1 replication and CD4+ T-cell depletion in human lymphoid tissue ex vivo.
    Rücker E; Grivel JC; Münch J; Kirchhoff F; Margolis L
    J Virol; 2004 Nov; 78(22):12689-93. PubMed ID: 15507658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus vpr gene encodes a virion-associated protein.
    Yuan X; Matsuda Z; Matsuda M; Essex M; Lee TH
    AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1265-71. PubMed ID: 2150318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transactivation is a conserved function among primate lentivirus Vpr proteins but is not shared by Vpx.
    Philippon V; Matsuda Z; Essex M
    J Hum Virol; 1999; 2(3):167-74. PubMed ID: 10413368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo.
    Goh WC; Rogel ME; Kinsey CM; Michael SF; Fultz PN; Nowak MA; Hahn BH; Emerman M
    Nat Med; 1998 Jan; 4(1):65-71. PubMed ID: 9427608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.